Your cart
There are no more items in your cart
The drug has the ability to specifically lyse the bacteria of staphylococci, streptococci (including enterococci), Proteus, Klebsiella pneumonia, Pseudomonas aeruginosa and Escherichia coli.
- treatment and prevention of purulent-inflammatory and enteral diseases caused by staphylococci, streptococci, Proteus, Klebsiella, Pseudomonas aeruginosa and Escherichia coli:
- diseases of the ear, throat, nose, respiratory tract and lungs - inflammation of the sinuses, middle ear, tonsillitis, pharyngitis, laryngitis, tracheitis, bronchitis, pneumonia, pleurisy;
- surgical infections - suppuration of wounds, burns, abscess, phlegmon, boils, carbuncles, hydroadenitis, felons, paraproctitis, mastitis, bursitis, osteomyelitis;
- urogenital infections - urethritis, cystitis, pyelonephritis, colpitis, endometritis, salpingo-oophoritis;
- post-traumatic conjunctivitis, keratoconjunctivitis, purulent corneal ulcers and iridocyclitis;
- enteric infections - gastroenterocolitis, cholecystitis, dysbacteriosis;
- generalized septic diseases;
- purulent-inflammatory diseases of newborns - omphalitis, pyoderma, conjunctivitis, gastroenterocolitis, sepsis, etc.;
- other diseases caused by bacteria of staphylococci, streptococci (including enterococci), Proteus, Klebsiella pneumonia, Pseudomonas aeruginosa and Escherichia coli.
In severe manifestations of infections caused by staphylococci, streptococci, Proteus, Klebsiella pneumonia, Pseudomonas aeruginosa and Escherichia coli, the drug is prescribed as part of complex therapy.
For prophylactic purposes, the drug is used to treat surgical and freshly infected wounds, as well as to prevent nosocomial infections according to epidemic indications.
An important condition for effective phage therapy is the preliminary determination of the phage sensitivity of the pathogen.
Before use, the bacteriophage vial must be shaken and viewed. The drug should be clear and free of sediment.
Treatment of purulent-inflammatory diseases with localized lesions should be carried out simultaneously both locally and by taking the drug orally for 7-20 days (according to clinical indications).
If chemical antiseptics were used to treat wounds before using the bacteriophage, the wound should be thoroughly washed with a sterile 0.9% sodium chloride solution.
Solution for oral administration, local and external use
COMPOSITION: Sterile purified filtrates of phagolysates of bacteria Staphylococcus spp., Streptococcus spp., Proteus (P. vulgaris, P. mirabilis), Pseudomonas aeruginosa, Klebsiella pneumoniae, enteropathogenic Escherichia coli (with Appelman activity - at least 10-5) - up to 1 ml.
- treatment and prevention of purulent-inflammatory and enteral diseases caused by staphylococci, streptococci, Proteus, Klebsiella, Pseudomonas aeruginosa and Escherichia coli:
- diseases of the ear, throat, nose, respiratory tract and lungs - inflammation of the sinuses, middle ear, tonsillitis, pharyngitis, laryngitis, tracheitis, bronchitis, pneumonia, pleurisy;
- surgical infections - suppuration of wounds, burns, abscess, phlegmon, boils, carbuncles, hydroadenitis, felons, paraproctitis, mastitis, bursitis, osteomyelitis;
- urogenital infections - urethritis, cystitis, pyelonephritis, colpitis, endometritis, salpingo-oophoritis;
- post-traumatic conjunctivitis, keratoconjunctivitis, purulent corneal ulcers and iridocyclitis;
- enteric infections - gastroenterocolitis, cholecystitis, dysbacteriosis;
- generalized septic diseases;
- purulent-inflammatory diseases of newborns - omphalitis, pyoderma, conjunctivitis, gastroenterocolitis, sepsis, etc.;
- other diseases caused by bacteria of staphylococci, streptococci (including enterococci), Proteus, Klebsiella pneumonia, Pseudomonas aeruginosa and Escherichia coli.
In severe manifestations of infections caused by staphylococci, streptococci, Proteus, Klebsiella pneumonia, Pseudomonas aeruginosa and Escherichia coli, the drug is prescribed as part of complex therapy.
For prophylactic purposes, the drug is used to treat surgical and freshly infected wounds, as well as to prevent nosocomial infections according to epidemic indications.
An important condition for effective phage therapy is the preliminary determination of the phage sensitivity of the pathogen.
Before use, the bacteriophage vial must be shaken and viewed. The drug should be clear and free of sediment.
Treatment of purulent-inflammatory diseases with localized lesions should be carried out simultaneously both locally and by taking the drug orally for 7-20 days (according to clinical indications).
If chemical antiseptics were used to treat wounds before using the bacteriophage, the wound should be thoroughly washed with a sterile 0.9% sodium chloride solution.
Solution for oral administration, local and external use
| AGE OF THE PATIENT | Dose of the drug (ml) | |
|---|---|---|
| ORAL | RECTAL | |
| 0 – 6 months | 5 | 10 |
| 6 – 12 months | 10 | 20 |
| 1 - 3 years | 15 | 20-30 |
| 3-8 years | 20 | 30-40 |
| 8 years and older | 20-30 | 40-50 |
4602784002612
$6.69
Out-of-Stock
Customers who bought this product also bought:
- New
Special treatments
Teana Fungusto 10 day Face Serum Beauty Regimen based on mushrooms extracts 10x2ml /...
4680003062531
$9.72
- New
Customers who bought this product also bought:
- New
Out-of-Stock
$7.36
$6.69
Tap to zoom
